Related Experiment Videos
High-dose adjuvant interferon therapy for melanoma
1Department of Medicine, University of Vermont College of Medicine, Burlington, USA.
Dermatology Nursing
|January 5, 1999
Abstract:
High-dose interferon has recently been approved as an adjuvant to surgery for treating newly diagnosed patients at high-risk for melanoma, particularly those with regional lymph node disease. The data supporting the indications for treatment and its side effects are reviewed.